Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The VSports app下载. gov means it’s official. Federal government websites often end in . gov or . mil. Before sharing sensitive information, make sure you’re on a federal government site. .

Https

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely V体育官网. .

. 2013:2013:846039.
doi: 10.1155/2013/846039. Epub 2013 Jun 16.

Biochanin a promotes osteogenic but inhibits adipogenic differentiation: evidence with primary adipose-derived stem cells

Shu-Jem Su  1 , Yao-Tsung Yeh, Shu-Hui Su, Kee-Lung Chang, Huey-Wen Shyu, Kuan-Ming Chen, Hua Yeh
Affiliations

Biochanin a promotes osteogenic but inhibits adipogenic differentiation: evidence with primary adipose-derived stem cells (VSports在线直播)

Shu-Jem Su et al. Evid Based Complement Alternat Med. 2013.

VSports在线直播 - Abstract

Biochanin A has promising effects on bone formation in vivo, although the underlying mechanism remains unclear yet. This study therefore aimed to investigate whether biochanin A regulates osteogenic and adipogenic differentiation using primary adipose-derived stem cells. The effects of biochanin A (at a physiologically relevant concentration of 0. 1-1 μM) were assessed in vitro using various approaches, including Oil red O staining, Nile red staining, alizarin red S staining, alkaline phosphatase (ALP) activity, flow cytometry, RT-PCR, and western blotting VSports手机版. The results showed that biochanin A significantly suppressed adipocyte differentiation, as demonstrated by the inhibition of cytoplasmic lipid droplet accumulation, along with the inhibition of peroxisome proliferator-activated receptor gamma (PPAR γ ), lipoprotein lipase (LPL), and leptin and osteopontin (OPN) mRNA expression, in a dose-dependent manner. On the other hand, treatment of cells with 0. 3 μM biochanin A increased the mineralization and ALP activity, and stimulated the expression of the osteogenic marker genes ALP and osteocalcin (OCN). Furthermore, biochanin A induced the expression of runt-related transcription factor 2 (Runx2), osteoprotegerin (OPG), and Ras homolog gene family, member A (RhoA) proteins. These observations suggest that biochanin A prevents adipogenesis, enhances osteoblast differentiation in mesenchymal stem cells, and has beneficial regulatory effects in bone formation. .

PubMed Disclaimer

Figures

Figure 1
Figure 1
Biochanin A (BA) inhibited the adipogenic differentiation of ADSCs. ADSCs were treated for 12 days with a basic medium (negative control) or an adipogenic medium (MDI) in the presence of 0.1–1 μM biochanin A. (a) After 12 days of incubation, the cells were fixed and adipogenic differentiation was determined by the Oil red O staining of lipid droplets. Morphological changes in cells were observed using a light microscope (upper and lower panel, original magnification: 200x). Lipid droplets were quantified using Oil red O dissolved in isopropanol and by determining absorbance at 490 nm. (b) After 12 days of incubation, the cells were harvested, fixed, and stained with Nile red solution. Percentage of Nile-red-stained cells in the total population of each sample was quantified with FACScan flow cytometry. All results are expressed as the mean ± SD of three independent experiments. *P < 0.05 compared with the control.
Figure 2
Figure 2
Biochanin A inhibited the expression of adipogenesis-related factors in ADSCs. ADSCs were treated for 12 days with a basic medium (negative control) or an adipogenic medium (MDI) in the presence of 0.1–1 μM biochanin A. After 12 days of incubation, the expression of PPARγ, LPL, leptin, and OPN mRNA was measured by RT-PCR. GAPDH expression was used for normalization. All results are expressed as the mean ± SD of three independent experiments. *P < 0.05 compared with the control.
Figure 3
Figure 3
Biochanin A inhibited the expression of adipogenesis-related cytokines in ADSCs. ADSCs were treated for 12 days with a basic medium (negative control) or an adipogenic medium (MDI) in the presence of 0.1–1 μM biochanin A. After 12 days of incubation, expression of TNFα and IL-6 mRNA was measured by RT-PCR. GAPDH expression was used for normalization. All results are expressed as the mean ± SD of three independent experiments. *P < 0.05 compared with the control.
Figure 4
Figure 4
Biochanin A enhanced the osteogenic differentiation in ADSCs. ADSCs were treated for 12 days with a basic medium (negative control) or an osteogenic medium (OM) in the presence of 0.1–1 μM biochanin A. (a) Osteogenic differentiation was determined by alizarin red S staining of calcium deposits (mineralization) within the cell monolayer. (b) ALP activity was determined using the ALP assay kit according to the manufacturer's protocol. All results are expressed as the mean ± SD of three independent experiments. *P < 0.05 compared with the control.
Figure 5
Figure 5
Biochanin A enhanced the expression levels of genes and proteins that regulate osteogenic differentiation in ADSCs. ADSCs were treated for 12 days with a basic medium (negative control) or an osteogenic medium (OM) in the presence of 0.1–1 μM biochanin A. (a) After incubation, expression of ALP, OCN, and GAPDH mRNA was measured by RT-PCR. Expression of ALP and OCN genes was normalized to that of GAPDH. (b) After incubation, total proteins were isolated and analyzed for the expression of OPG, Runx2, Sirt1, and RhoA proteins by western blot analysis. β-actin was used as the internal control. All results are expressed as the mean ± SD of three independent experiments. *P < 0.05 compared with the control.
See this image and copyright information in PMC

References

    1. Rosen CJ, Bouxsein ML. Mechanisms of disease: is osteoporosis the obesity of bone? Nature Clinical Practice Rheumatology. 2006;2(1):35–43. - PubMed
    1. Justesen J, Stenderup K, Eriksen EF, Kassem M. Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures. Calcified Tissue International. 2002;71(1):36–44. - PubMed
    1. Nuttall ME, Gimble JM. Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Current Opinion in Pharmacology. 2004;4(3):290–294. - "V体育官网入口" PubMed
    1. Rodriguez JP, Montecinos L, Rios S, Reyes P, Martinez J. Mesenchymal stem cells from osteoporotic patients produce a type I collagen-deficient extracellular matrix favoring adipogenic differentiation. Journal of Cellular Biochemistry. 2000;79(4):557–565. - PubMed
    1. Astudillo P, Ríos S, Pastenes L, Pino AM, Rodríguez JP. Increased adipogenesis of osteoporotic human-mesenchymal stem cells (MSCs) is characterized by impaired leptin action. Journal of Cellular Biochemistry. 2008;103(4):1054–1065. - PubMed

LinkOut - more resources